- Home
- FCCO vs SRZN Comparison
FCCO vs SRZN Comparison
Compare FCCO & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCCO | SRZN |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 290.5M | 271.6M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | FCCO | SRZN |
|---|---|---|
| Price | $32.07 | $22.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | 84.7K | ★ 169.9K |
| Earning Date | 04-22-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | ★ 36.46 | N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $922,000.00 | N/A |
| Revenue This Year | $30.67 | $75.35 |
| Revenue Next Year | $5.87 | N/A |
| P/E Ratio | $54.86 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.12 | $8.21 |
| 52 Week High | $34.01 | $35.00 |
Technical Indicators
Market Signals| Indicator | FCCO | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 50.41 | 46.69 |
| Support Level | $31.98 | $20.26 |
| Resistance Level | $33.03 | $24.50 |
| Average True Range (ATR) | 0.87 | 1.85 |
| MACD | -0.11 | -0.05 |
| Stochastic Oscillator | 17.80 | 42.76 |
Price Performance
Historical ComparisonAbout FCCO First Community Corporation
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are: Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).